Diazoxide choline (Vykat XR) for treatment of hyperphagia and obesity in Prader-Willi syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine Open · 2026-08 · 104412
DOI: 10.1016/j.gimo.2026.104412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine Open, 2026-08. Verfasst von Nadia Merchant und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Merchant, N., Neira, J., Derry, A., & Gropman, A. L. (2026). Diazoxide choline (Vykat XR) for treatment of hyperphagia and obesity in Prader-Willi syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open, 104412. https://doi.org/10.1016/j.gimo.2026.104412
Vancouver
Merchant N, Neira J, Derry A, Gropman AL. Diazoxide choline (Vykat XR) for treatment of hyperphagia and obesity in Prader-Willi syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. 2026:104412. doi:10.1016/j.gimo.2026.104412
BibTeX
@article{Merchant2026,
author = {Merchant, Nadia and Neira, Juanita and Derry, Allyson and Gropman, Andrea L.},
title = {Diazoxide choline (Vykat XR) for treatment of hyperphagia and obesity in Prader-Willi syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)},
journal = {Genetics in Medicine Open},
year = {2026},
pages = {104412},
doi = {10.1016/j.gimo.2026.104412}
}
EUVIMED